Literature DB >> 12374772

IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C.

Otilia Obreja1, Parvinder K Rathee, Kathrin S Lips, Carsten Distler, Michaela Kress.   

Abstract

Interleukin 1 beta (IL-1 beta) is a proinflammatory cytokine that maintains thermal hyperalgesia and facilitates the release of calcitonin gene-related peptide from rat cutaneous nociceptors in vivo and in vitro. Brief applications of IL-1 beta to nociceptive neurons yielded a potentiation of heat-activated inward currents (Iheat) and a shift of activation threshold toward lower temperature without altering intracellular calcium levels. The IL-1 beta-induced heat sensitization was not dependent on G-protein-coupled receptors but was mediated by activation of protein kinases. The nonspecific protein kinase inhibitor staurosporine, the specific protein kinase C inhibitor bisindolylmaleimide BIM1, and the protein tyrosine kinase inhibitor genistein reduced the sensitizing effect of IL-1 beta whereas negative controls were ineffective. RT-PCR and in situ hybridization revealed IL-1RI but not RII expression in neurons rather than surrounding satellite cells in rat dorsal root ganglia. IL-1 beta acts on sensory neurons to increase their susceptibility for noxious heat via an IL-1RI/PTK/PKC-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374772     DOI: 10.1096/fj.02-0101com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  73 in total

1.  Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors.

Authors:  Xichun Zhang; Rami Burstein; Dan Levy
Journal:  Cephalalgia       Date:  2011-12-05       Impact factor: 6.292

2.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

Review 3.  The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs.

Authors:  Haroon Hameed; Mariam Hameed; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-04

4.  Cytokine expression in the epidural space: a model of noncompressive disc herniation-induced inflammation.

Authors:  Jason M Cuéllar; Paula M Borges; Vanessa Gabrovsky Cuéllar; Andrew Yoo; Gaetano J Scuderi; David C Yeomans
Journal:  Spine (Phila Pa 1976)       Date:  2013-01-01       Impact factor: 3.468

5.  Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: Contribution of prolactin receptor to inflammatory pain.

Authors:  Mayur J Patil; Shivani B Ruparel; Michael A Henry; Armen N Akopian
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-10       Impact factor: 4.310

Review 6.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

7.  Physiology and pharmacology of the vanilloid receptor.

Authors:  Angel Messeguer; Rosa Planells-Cases; Antonio Ferrer-Montiel
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 8.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

9.  Antinociceptive effects of dezocine on complete Freund's adjuvant-induced inflammatory pain in rats.

Authors:  Zhenhai Ye; Maoxian Zhang; Ning Ding; Peng Gao; Yunpeng Hei; Yun Wang; Wei Gao; Qingshan Ye
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

10.  Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic Receptors.

Authors:  Brittney P Ciszek; Sandra C O'Buckley; Andrea G Nackley
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.